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Abstract Freshly established cultures of primary hepa-
tocytes progressively adopt a foetal-like phenotype and
display increased production of connexin43. The latter is a
multifaceted cellular entity with variable subcellular loca-
tions, including the mitochondrial compartment. Cx43
forms hemichannels and gap junctions that are involved in a
plethora of physiological and pathological processes, such
as apoptosis. The present study was conducted with the goal
of shedding more light onto the role of connexin43 in pri-
mary hepatocyte cultures. Connexin43 expression was
suppressed by means of RNA interference technology, and
the overall outcome of this treatment on the hepatocellular
proteome and metabolome was investigated using tan-
dem mass tag-based differential protein profiling and 1H
NMR spectroscopy, respectively. Global protein profiling
revealed a number of targets of the connexin43 knock-down
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procedure, including mitochondrial proteins (heat shock
protein 60, glucose-regulated protein 75, thiosulphate sul-
phurtransferase and adenosine triphosphate synthase) and
detoxifying enzymes (glutathione S-transferase l 2 and
cytochrome P450 2C70). At the metabolomic level, conn-
exin43 silencing caused no overt changes, though there was
some evidence for a subtle increase in intracellular glycine
quantities. Collectively, these data could further substanti-
ate the established existence of a mitochondrial connexin
pool and could be reconciled with the previously reported
involvement of connexin43 signalling in spontaneously
occurring apoptosis in primary hepatocyte cultures.









GRP75 Glucose-regulated protein 75
HSP60 Heat shock protein 60
IPI International protein index
LC/MS Liquid chromatography/mass spectrometry
LOWESS Locally weighted scatterplot smoothing
LTQ Linear ion trap
NMR Nuclear magnetic resonance
OT Orbitrap
PbAE2 1,6-Hexanediol diacrylate-based poly-beta-
aminoester
PBS Phosphate-buffered saline solution
RF Relative frequence
SDS–PAGE Sodium dodecyl sulphate polyacrylamide
gel electrophoresis
siRNA Small interfering RNA
TBS Tris-buffered saline solution
TMT Tandem mass tags
TSP Trimethylsilyltetradeuteropropionic acid
Introduction
Connexin (Cx) proteins and their channels constitute three
levels of cellular communication. First, connexins assemble
into hexameric structures, called hemichannels, which dock
in pairs at the cell plasma membrane surface to generate
gap junctions between neighbouring cells. Gap junctional
intercellular communication implies the passive diffusion
of small and hydrophilic substances, including glucose,
glutamate, glutathione, adenosine triphosphate (ATP),
cyclic adenosine monophosphate, inositol trisphosphate and
ions. Undocked hemichannels create a second platform for
communication, by connecting the cytosol with the extra-
cellular environment and by conveying essential metabo-
lites, like ATP, nicotinamide adenine dinucleotide,
glutamate, prostaglandins and glutathione. Hemichannels
can also reside at atypical subcellular locations, such as in
mitochondria, where they are thought to serve as a conduit
for ion fluxes. A third level of communication is formed by
connexin proteins themselves, which can affect gene
expression patterns independently of gap junction or hemi-
channel functionality (Decrock et al. 2009; Vinken et al.
2006a, 2011a). The interplay between these three cellular
signalling routes is not only of major importance for the
maintenance of tissue homeostasis, but also fulfils a key
function in a variety of pathological events, including cell
death, inflammation, oxidative stress and ischaemic insults
(Decrock et al. 2009).
Cultures of primary hepatocytes are prominent in vitro
models in pharmacotoxicology (Elaut et al. 2006; Hewitt
et al. 2007). However, they are prone to dedifferentiation,
which is caused, at least in part, through the induction of an
inflammatory response during their isolation from the
freshly acquired liver tissue and which is followed by the
onset of cell death during their subsequent cultivation (Elaut
et al. 2006; Vinken et al. 2006b, 2011b). This deteriorative
process is associated with a transition in connexin expres-
sion. Indeed, in the adult liver, hepatocytes abundantly
produce Cx32, but in culture, they switch to Cx43 (Vinken
et al. 2006b). The biological relevance of induced hepato-
cellular Cx43 expression in primary hepatocyte cultures, a
process also observed in vivo during hepatocarcinogenesis
(Vinken et al. 2008), remains obscure. We previously
showed that Cx43 is not involved in the loss of the differ-
entiated phenotype per se (Vinken et al. 2012a), but rather
plays a permissive role in spontaneous apoptosis in primary
hepatocyte cultures by involving both gap junction and
hemichannel activity (Vinken et al. 2012b). In the current
study, we investigate whether Cx43 protein as such can
affect hepatocellular protein production and endogenous
metabolism in vitro at a global scale. To this end, Cx43
expression was suppressed in primary hepatocyte cultures
through RNA interference technology followed by evalua-
tion of the resulting proteomic and metabolomic profiles.
Materials and methods
Chemicals and reagents
The 1,6-hexanediol diacrylate-based poly-beta-aminoes-
ter (PbAE2) was synthesized as described elsewhere
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(Vandenbroucke et al. 2008). For liquid chromatography
(LC)/mass spectrometry (MS) analysis, all solvents and
additives were of ultragrade performance LC grade quality
(Biosolve, the Netherlands). All other chemicals were com-
mercially available products of analytical grade and were
supplied by Sigma (Belgium), unless specified otherwise.
Hepatocyte isolation and cultivation
Procedures for the housing of rats, and isolation and culti-
vation of hepatocytes were approved by the local ethical
committee of the Vrije Universiteit Brussel (Belgium). Male
outbred Sprague–Dawley rats (Charles River Laboratories,
Belgium) were kept under controlled environmental condi-
tions with free access to food and water. Hepatocytes were
isolated using a two-step collagenase method, including
purification by serial differential centrifugation, and cell
viability was assessed by trypan blue exclusion (Papeleu
et al. 2006). Viable (C85 %) hepatocytes were plated at a
density of 0.56 9 105 cells/cm2 in William’s medium E
(Invitrogen, Belgium) supplemented with 7 ng/ml glucagon,
292 mg/ml L-glutamine, antibiotics (7.33 I.E./ml sodium
benzyl penicillin, 50 lg/ml kanamycin monosulphate,
10 lg/ml sodium ampicillin and 50 lg/ml streptomycin
sulphate) and 10 % foetal bovine serum. After 4 h, 1 day,
2 days and 3 days, the cell culture medium was removed and
replaced by serum-free medium supplemented with 25 lg/
ml hydrocortisone sodium hemisuccinate and 0.5 lg/ml
insulin (‘‘hepatocyte culture medium’’). Samples were taken
on day 1 and day 4 of the cultivation period.
Small interfering RNA transfection
Cx43 expression was suppressed by small interfering RNA
(siRNA) treatment with On-target plus smart pool siRNA
from Dharmacon (Belgium), which contains four different
siRNA duplexes directed against rat gja1 (sense strand
sequences: siRNA number 1: 50-CAACAACCUGGCUGC
GAAAUU-30; siRNA number 2: 50-UGAUUGAAAUGUC
GAGUUAUU-30; siRNA number 3: 50-CGUGAAGGGAA
GAAGCGAUUU-30; siRNA number 4: 50-UUACUGAGA
UUCUGCGAUAUU-30). Preparation of PbAE2/siRNA
complexes was carried out as previously described
(Vandenbroucke et al. 2008; Vinken et al. 2012a, b). The
siRNA transfection was started 20 h after cell seeding by
replacing the initial cell culture medium by hepatocyte
culture medium, containing the PbAE2/siRNA complexes
(final siRNA concentration 100 nM). After 5 h, the cell
culture medium was removed and replaced by regular
hepatocyte culture medium. The hepatocyte culture
medium was renewed another two times (19 h and 43 h
post-transfection), and sampling was performed 72 h post-
transfection (i.e., at day 4 of the cultivation period).
Experiments with non-targeting siRNA (Dharmacon, Bel-
gium) were performed in parallel.
Proteomics analysis
For the preparation of total protein lysates, hepatocytes were
harvested from cell culture plates by scraping and washed
twice with cold phosphate-buffered saline solution (PBS).
Pelleted cells were lysed by addition of radio-immunopre-
cipitation lysis buffer (Thermo Fisher Scientific, Germany)
complemented with 1 % phosphatase inhibitor (Thermo
Fisher Scientific, Germany) and 1 % protease inhibitor
(Thermo Fisher Scientific, Germany). Following controlled
sonication and cooled (4 C) centrifugation for 5 min at
14,0009g, the supernatant was used for protein concentra-
tion determination using a BCA Protein Assay kit (Pierce,
Belgium). Samples were spiked with 1 % casein-b and 1 %
Rapigest SF Surfactant (Waters, Belgium), incubated at
100 C for 5 min, mixed and chilled at 4 C. Equal amounts
of protein extracts obtained from three biological replicas
were pooled. Each pooled sample was subjected to acetone-
based protein precipitation followed by in-solution tryptic
proteolysis. The resulting digest was prepared for isotopic
peptide labelling using tandem mass tag (TMT) kits and
reagents (Thermo Fisher Scientific, Germany) according to
the manufacturer’s protocol. In addition to the three experi-
mental conditions (i.e., Cx43 siRNA, non-targeting siRNA
and control), an additional sample was reconstituted from
equal amounts of the three experimental conditions and was
used for normalization purposes during quantitative data
analysis. The final multiplexed sample was reconstituted
from equal amounts of each labelled condition and subjected
to three replicate LC/MS analyses. Nanoflow LC/MS/MS
was performed on a dual binary channel nanoLC Ultra 2D
system (Eksigent, United States of America) connected to a
linear ion trap (LTQ) Velos Orbitrap (OT) mass spectrometer
(Thermo Fisher Electron, Germany), equipped with a Tri-
versa chip-based electrospray source (Advion Biosystems,
United States of America) operating at 1.8 kV. A volume of
10 lL, representing a predigest protein load of 1 lg, was
loaded on a C18 precolumn (PepMap 100, 5 lm particles,
20 mm 9 200 lm internal diameter, Dionex, United States
of America). After 5 min, the trapping column was switched
in line with an analytical C18 column (Acclaim Pepmap 100,
3 lm particles, 150 mm 9 75 lm internal diameter) (Dio-
nex, United States of America). Gradient elution of peptides
was accomplished during a 70-min run. Peptide MS spectra
were recorded in the OT with a resolution of 60,000 at m/z
400. The maximum injection time was set to 500 ms for both
LTQ and OT, and lock mass was enabled with polysiloxane
ion at m/z 445.12024. Up to five co-eluting peptide masses
were selected in data-dependent acquisition (DDA) mode
for interrogation on tandem MS. Recurrent masses were
Arch Toxicol (2013) 87:883–894 885
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dynamically excluded from DDA selection during 30 s. The
set of selected peptides was analysed by two different mass
spectral settings to ascertain an optimal information retrieval.
First, a low-energy collision- induced dissociation regime in
the LTQ analyser was applied to generate reliable and
complementary peptide sequence fragmentation data. Sec-
ondly, high-collision energy fragmentation regime in the OT
analyser was applied in order to establish reliable TMT
reporter ions for robust quantification (Kocher et al. 2009).
Raw files of the three replicate analyses were processed via
the Proteome Discoverer work flow manager version 2.0
(Thermo Fisher Scientific, United States of America). For
peptide identification, fragmentation spectra from both ana-
lysers were used for database searches against international
protein index (IPI) rat (ipi.RAT.v3.87 containing 39,925
dbase entries) (Kersey et al. 2004) using Sequest version
1.0.43 embedded in Proteome Discoverer 2.0. Carbami-
domethylation and the modification of the N-termini and
lysine by the TMT-reactive group were set as fixed modifi-
cations, while oxidation was set as variable modification.
Peptide mass tolerance was set at 5 ppm, and fragment mass
tolerance was set to 0.5 Da and 20 millimass units for the
LTQ and OT, respectively. Two missed cleavages were
allowed. For confident and high-confident peptide identifi-
cation, a threshold scheme based on the Sequest Xcorr score
was used. The thresholds depend on the charge state of the
fragmented molecular ion (Supplementary Table S1). This
resulted in a final total of 1,790 rat proteins identified. A gene
ontology (GO) analysis of the proteins showed that all major
cellular components were sampled (data not shown) and
indicated that the sampled set of proteins did not suffer from
any major sample preparation bias. A comparative GO pro-
file of the identified hepatocyte proteins was compared with
the total rat GO profile and indicated significant enrichment
or depletion for hepatocyte-specific cellular components,
cellular functions and metabolic processes (Supplementary
Table S2). The false discovery rate was assessed by a target-
decoy approach using the reversed sequences of IPI rat. By
using the threshold scheme, false discovery rate values of
0.0487 and 0.0081 were obtained for the confident and high-
confident peptides, respectively. This reporter ion informa-
tion was extracted from the tandem MS with a mass tolerance
of 20 ppm. In the case multiple ions were present within the
mass tolerance, the most confident peak was selected.
Reporter intensities were normalized to remove systematic
effects and possible confounders using a locally weighted
scatterplot smoothing (LOWESS) normalization (Yang et al.
2002).
Immunoblotting
For the preparation of total protein lysates, hepatocytes
were harvested from cell culture plates by scraping and
washed twice with cold PBS. Cells were homogenized
in lysis buffer (50 mM Hepes, 150 mM NaCl, 1 mM
ethylenediamine tetra-acetic acid, 2.5 mM ethyleneglycol
tetra-acetic acid, 0.1 % Tween 20 and 10 % glycerol)
supplemented with 0.1 mM phenylmethylsulphonyl-
fluoride, 5 mM dithiothreitol and protease inhibitor
cocktail (Roche, Germany). Following sonication for
10 s, samples were left on ice for 1 h. Cell lysates were
centrifuged at 13,7919g for 5 min, and protein concen-
trations were determined in the supernatants according to
the Bradford procedure (Bradford 1976) using a Bio-Rad
protein assay kit (Bio-Rad, Germany). Proteins were
fractionated on sodium dodecyl sulphate polyacrylamide
(SDS–PAGE) and blotted afterwards onto nitrocellulose
membranes (Amersham, UK). Blocking of the mem-
branes was performed with 5 % non-fatty milk in Tris-
buffered saline solution (TBS; 20 mM Tris, 135 mM
NaCl) containing 0.1 % Tween 20. Membranes were
incubated overnight at 4 C with a primary antibody
directed against Cx32, Cx43, heat shock protein 60
(HSP60) or glucose-regulated protein 75 (GRP75)
(Table 1), followed by incubation for 1 h at room tem-
perature with appropriate horseradish peroxidase-conju-
gated secondary antibodies (Dako, Denmark). Excessive
antibody was removed by washing the membranes in
Tween-supplemented TBS. The proteins were detected
by means of an enhanced chemiluminescence Western
blotting system (Amersham, United Kingdom). For semi-
quantification of the results, blots were further incu-
bated with a glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) antibody (Abcam, United Kingdom). Blots
were scanned, and densitometric analyses were performed
by using the Quantity One software (Bio-Rad, Germany).
For Cx43, marker signals in the non-targeting siRNA and
the Cx43 siRNA conditions were normalized to the cor-
responding GAPDH signals and were expressed as per-
centage of the normalized marker signals in the untreated
control condition. For HSP60 and GRP75, marker signals
in the Cx43 siRNA condition were normalized to the
corresponding GAPDH signals and were expressed as
percentage of the normalized marker signals in the non-
targeting siRNA condition.
Table 1 Primary antibodies used for immunoblot analysis
Antigen Supplier Reference Species Type Dilution
Cx32 Sigma C3470 Rabbit Polyclonal 1/500
Cx43 Sigma C6219 Rabbit Polyclonal 1/4,000
HSP60 Santa Cruz sc13966 Rabbit Polyclonal 1/1,000
GRP75 Santa Cruz sc13967 Rabbit Polyclonal 1/1,000
GAPDH Abcam ab8245 Mouse Monoclonal 1/20,000
886 Arch Toxicol (2013) 87:883–894
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Metabolomics analysis
Intracellular (i.e., aqueous cell fractions) and extracellular
(i.e., cell culture media) samples of the primary rat hepa-
tocyte cultures were prepared as previously described (Ellis
et al. 2011). Aqueous soluble metabolites (i.e., intracellular
fractions) were isolated from hepatocytes using a chloro-
form/methanol/water extraction method. After fraction-
ation, the samples were allowed to evaporate at room
temperature for about 12 h to remove any organic solvent,
and the remainder was freeze-dried. The lyophilized sam-
ple was then reconstituted in 600 lL of phosphate buffer
and centrifuged for 5 min at 16,0009g before being
transferred to a standard 5-mm glass nuclear magnetic
resonance (NMR) tube. The cell culture media (i.e.,
extracellular fractions) were prepared for spectroscopic
analysis by adding 50 lL of D2O containing 0.2 % tri-
methylsilyltetradeuteropropionic acid (TSP) to 550 lL of
cell culture media sample, of which 550 lL was transferred
to a standard 5-mm NMR tube. All reagents were checked
prior to sample preparation by obtaining 1D 1H NMR
spectra to ensure that they contained no contaminants that
could interfere with the downstream spectroscopic analy-
sis. For NMR spectroscopy, high-resolution 1D 1H NMR
spectra of intracellular and extracellular samples were
acquired at 14.1 T (600.13 MHz 1H frequency) using a
Bruker Avance 600 spectrometer (Bruker Biospin, Ger-
many) fitted with a 5-mm tube probehead and a Bacs 60
automated sample changer (Bruker BioSpi, Germany).
Acquisition of spectra was controlled using Xwin-NMR
and Icon-NMR (Bruker Biospin, Germany). Automatic
shimming was used to improve the magnetic field homo-
geneity prior to the acquisition of spectral data for each
sample. Carr-Purcell-Meiboom-Gill 1H spectra were obtained
using the pulse sequence (RD-90-[s-180-s]n-AQ). The
fixed echo time (s) was set at 400 ls, with a total spin-echo
time of 64 ms. During the acquisition period (AQ, 2.73 s),
the free induction decay was recorded into 64 k datapoints
in the time domain, with a spectral width of 20 ppm.
Fig. 1 Connexin expression in primary hepatocyte cultures. Freshly
isolated rat hepatocytes were cultivated in a monolayer configuration.
Samples were taken on day 1 and day 4 of the cultivation period and
subjected to immunoblot analysis as described in the ‘‘Materials and
methods’’ section, using primary antibodies that specifically recog-
nize Cx32 and Cx43 (Table 1). Blot shown is a representative of three
independent experiments
Fig. 2 Cx43 suppression in primary hepatocyte cultures. a Freshly
isolated rat hepatocytes were cultivated in a monolayer configuration.
Twenty hours after plating, cell cultures were transfected with
100 nM non-targeting siRNA or Cx43 siRNA for 5 h as described in
the ‘‘Materials and methods’’ section. Samples were taken 72 h post-
transfection and subjected to immunoblot analysis as described in the
‘‘Materials and methods’’ section, using a Cx32 or a Cx43 primary
antibody (Table 1). b For semi-quantification of the results, Cx32 or
Cx43 signals in the non-targeting siRNA and the Cx43 siRNA
conditions were normalized to the GAPDH corresponding signals and
were expressed as percentage of the normalized Cx32 (upper panel)
or Cx43 (lower panel) signals, respectively, in the control condition
(indicated with a dashed line). Data were expressed as mean ± SD of
four independent experiments. Results were evaluated by one-way
analysis of variance followed by post hoc Bonferroni tests. Asterisks
indicate significant differences compared with the non-targeting
siRNA condition (***p \ 0.001)
Arch Toxicol (2013) 87:883–894 887
123
Typically, spectra were recorded as the sum of 128 tran-
sients following 16 dummy scans. In both cases, suppres-
sion of the water resonance centred at dH 4.7 ppm was
achieved by the application of a presaturation pulse during
the relaxation delay. A line broadening of 0.3 Hz was
applied to each spectrum. Assignment of resonances to
specific metabolites was based on the Chenomx profiler in
the NMR suite 6.1 software (Chenomx Inc., Canada) and
in-house assignment databases. The assignment of intra-
cellular glycine was confirmed by addition of a pure
standard at a known concentration to the biological
samples.
Statistical analysis
For immunoblot analyses, data were expressed as mean ± SD
of at least three independent experiments. Results were eval-
uated by one-way analysis of variance followed by post hoc
Bonferroni tests. For the metabolomic analyses, NMR spec-
tral data were imported and processed in Matlab (Mathworks)
using in-house software compiled by Dr. T.M.D. Ebbels, Dr.
H.C. Keun, Dr. J.T. Pearce and Dr. R. Cavill. 1H NMR spectra
were automatically phased, baseline corrected, and referenced
and normalized to the TSP resonance at d 0. The spectra were
then normalized using a median fold change normalization
(Dieterle et al. 2006) before subsequent analysis. In total, 34
metabolites were assigned, and the peak edges of the least
overlapped peaks were manually defined for integration.
Differences between conditions were assessed using a
homoscedastic t-test.
Results
Connexin expression in primary hepatocyte cultures
Hepatocytes mainly harbour Cx32 in the adult liver (Vin-
ken et al. 2008). However, during isolation and cultivation
of primary hepatocytes, Cx32 steady-state protein levels
drastically decline, with only marginal Cx32 immunore-
activity at the end of the 4-day cultivation period (Fig. 1).
A number of mechanisms could underlie this deterioration
of Cx32 production, including oxidative stress, which is
triggered during the hepatocyte isolation procedure (Elaut
et al. 2006). Simultaneously, Cx43, a connexin species
only expressed by foetal hepatocytes and by adult non-
parenchymal cells in vivo (Vinken et al. 2008), becomes
gradually detectable. Cx43 hereby is observed as a dual-
band signal, representing non-phosphorylated Cx43
(40 kDa; lower band) and phosphorylated Cx43 (43 kDa;
upper band), of which the former is predominantly present
in primary hepatocyte cultures (Fig. 1). The molecular
mechanisms that drive this process are unclear, though a
recent study shows that Wnt signalling and hence altered
transcriptional regulation could explain Cx43 appearance
in primary hepatocyte cultures (Yamaji et al. 2011).
Cx43 suppression in primary hepatocyte cultures
RNA interference technology was used to investigate the
role of Cx43 in primary hepatocyte cultures. For this pur-
pose, four siRNA duplexes directed against Cx43 mRNA
Fig. 3 Effect of Cx43 suppression on the proteome in primary
hepatocyte cultures. Freshly isolated rat hepatocytes were cultivated
in a monolayer configuration. Twenty hours after plating, cell cultures
were transfected with 100 nM non-targeting siRNA or Cx43 siRNA
for 5 h as described in the ‘‘Materials and methods’’ section. Samples
were taken 72 h post-transfection and subjected to proteomics
analysis as described in the ‘‘Materials and methods’’ section.
a Data are shown in a MA-plot indicating the log2 ratio (M) versus
average log2 intensity (A) of the non-normalized reporter intensities
of the Cx43 siRNA and non-targeting siRNA conditions. The dots
indicate the results of the LOWESS regression. b Data are shown in a
histogram of the log2 ratio after LOWESS normalization. The vertical
lines indicate the 95 % CI
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were introduced into the hepatocytes by means of
PbAE2, a cationic biodegradable poly-beta-aminoester
(Vandenbroucke et al. 2008). Transfections with non-tar-
geting siRNA, bearing at least four mismatches with
known rat genes, were performed in parallel in order to
check the specificity of the method. Semi-quantitative
immunoblot analysis indicated a significant (p \ 0.001)
reduction in Cx43 protein amounts to 32.5 ± 4.7 % of the
control level in primary hepatocyte cultures exposed to
Cx43 siRNA, while Cx43 levels remained statistically
unchanged in non-targeting siRNA-treated cultures. Cx32
levels were unaffected by Cx43 siRNA, thus showing the
specificity of the method (Fig. 2a, b).
Effect of Cx43 suppression on the proteome in primary
hepatocyte cultures
Proteomics analysis was performed on samples taken from
primary hepatocyte cultures treated with Cx43 siRNA or
non-targeting siRNA as well as from their untreated
counterparts. Figure 3a displays the result of the normali-
zation on the log2 of the ratio between the Cx43 siRNA-
treated and non-targeting siRNA-treated reporter ions.
Scattered points are centred at the zero line, indicating that
there is no systematic bias in the quantification channels.
Furthermore, the paired abundance measures exhibit a clear
drop shape, which suggests that the variability changes
with the overall intensity level. From the population of
4,119 tandem MS spectra, 2.5 % upregulated and down-
regulated peptides were selected. The vertical lines in
Fig. 3b visualize the 95 % interval of reporter ion ratios
between the targeting sample and non-targeting sample.
Ratios that fell outside the interval were considered
potential candidates for optional investigation by Western
blot analysis. Only high-confident peptide identifications
were considered for further investigation.
In order to examine the effect of Cx43 suppression on
the overall proteome profile of the cultured hepatocytes,
a limited GO profile analysis was performed (Supple-
mentary Table S3). For that purpose, only the identified
proteins that were characterized with at least a 1.5-fold
change in relative abundance compared to the control
sample were used. It should be noted that peptide ratios
were adjusted by median normalization. In addition, the
selected proteins have an abundance variability of less
than 30 %, and the selected proteins were not present in
the list of significant altered proteins of the non-targeting
siRNA-treated cells. This resulted in a final set of 27
proteins (Supplementary Table S4). In total, 25 proteins
were changed in the non-targeting siRNA-treated cells
versus the control condition (Supplementary Table S5).
From this exercise, it was clear that the most affected
cellular compartment upon Cx43 suppression is the
mitochondrion, followed by the cytoplasm and the cellu-
lar membrane system. With respect to cellular function
and processes, this is reflected in the metal ion–binding
protein set, including members of the cytochrome protein
family, the actin and actin-binding protein family, chap-
erones, redox proteins and stress responsive proteins
(Supplementary Table S3). A list of 11 candidate proteins
for validation of the proteomics analysis was selected
thereof (Table 2). A number of these proteins were
studied in more detail by means of Western blot analysis
(Fig. 4). Since the log2 ratio data showed that mito-
chondrial 60-kDa heat shock protein (HSP60) and mito-
chondrial stress-70 protein/glucose-regulated protein 75
(GRP75) were among the most prominent negative and





-1.6 IPI00197129.1 Actin, aortic smooth muscle
IPI00189819.1 Actin, cytoplasmic 1
IPI00194087.3 Actin, a-cardiac muscle 1
IPI00896224.1 Actin, cytoplasmic 2
IPI00200455.1 Actin, c-enteric smooth muscle
IPI00189813.1 Actin, a-skeletal muscle
IPI00560160.2 43-kDa protein
IPI00948496.1 33-kDa protein
IPI00958161.1 Actin, c-1 propeptide-like
IPI00960010.1 b-actin FE-3 (fragment)
-1.5 IPI00339148.2 60-kDa heat shock protein, mitochondrial
-1.4 IPI00411230.3 Glutathione S-transferase l 2
-1.4 IPI00366293.3 Thiosulphate sulphurtransferase
IPI00952474.1 Uncharacterized protein
-1.2 IPI00389571.6 Keratin, type II cytoskeletal 8
-1.0 IPI00188804.1 60S acidic ribosomal protein P2
IPI00388179.1 Uncharacterized protein
IPI00734740.2 Uncharacterized protein
1.0 IPI00778443.1 Cytochrome P450 2C70
1.0 IPI00551812.1 ATP synthase subunit-b, mitochondrial
1.0 IPI00231555.1 Isoform PYBP1 of polypyrimidine tract-
binding protein 1





1.1 IPI00206624.1 78-kDa glucose-regulated protein
1.4 IPI00363265.3 Stress-70 protein, mitochondrial
Hepatocyte proteins, identified based on peptide homology, which
showed at least a twofold change in relative abundance upon treat-
ment with Cx43 siRNA are considered suitable for further validation.
Entries and protein descriptions are obtained from the IPI rat database
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positive targets of Cx43 siRNA, respectively, these pro-
teins were selected for further scrutiny. Whole cell lysates
were prepared of primary hepatocytes exposed to Cx43
siRNA and non-targeting siRNA and subjected to SDS–
PAGE analysis. Following immunoblotting, membranes
were incubated with primary antibodies directed against
HSP60 and GRP75, and signals were semi-quantified
through densitometry and by normalization against
GAPDH. By doing so, treatment with Cx43 siRNA was
found to significantly (p \ 0.05) downregulate hepato-
cellular HSP60 protein levels to 87.3 ± 3.2 % of the non-
targeting siRNA condition, while GRP75 quantities were
raised to 119.0 ± 4.8 % (Fig. 4).
Effect of Cx43 suppression on the metabolome
in primary hepatocyte cultures
Quenching of the Cx43 production caused no gross chan-
ges in the endogenous metabolism of the primary rat
hepatocytes at the intracellular or the extracellular level as
assessed by NMR-based metabolic profiling. Indeed, the
cells appeared to exhibit normal metabolic behaviour in the
Cx43 siRNA condition when compared to the control
samples, as determined by measuring certain metabolites
that represent important metabolic pathways or that are
related to changes observed in the proteomics analysis
(Table 2). Glucose (i.e., extracellular) and lactate and
Fig. 4 Validation of the proteomics analysis. Freshly isolated rat
hepatocytes were cultivated in a monolayer configuration. Twenty
hours after plating, cell cultures were transfected with 100 nM non-
targeting siRNA or Cx43 siRNA for 5 h as described in the
‘‘Materials and methods’’ section. Samples were taken 72 h post-
transfection and subjected to immunoblot analysis as described in the
‘‘Materials and methods’’ section, using primary antibodies directed
against HSP60 or GRP75 (Table 1). For semi-quantification of the
results, marker signals in the Cx43 siRNA condition were normalized
to the corresponding GAPDH signals and were expressed as
percentage of the normalized marker signals in the non-targeting
siRNA condition (indicated with a dashed line). Data were expressed
as mean ± SD of seven independent experiments. Results were
evaluated by one-way analysis of variance followed by post hoc
Bonferroni tests. Asterisks indicate significant differences compared
with the non-targeting siRNA condition (*p \ 0.05)
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pyruvate (i.e., extracellular and intracellular) were moni-
tored to investigate possible glycolytic modifications in the
Cx43 siRNA condition. No significant changes associated
with treatment were observed. Proteomics analysis showed
a decrease in glutathione S-transferase levels by Cx43
siRNA (Table 2), but there was no concomitant alteration
in the oxidized and reduced glutathione pool. Visual
inspection of the normalized median spectra suggested a
Fig. 5 Effect of Cx43 suppression on the metabolome in primary
hepatocyte cultures. Freshly isolated rat hepatocytes were cultivated in
a monolayer configuration. Twenty hours after plating, cell cultures
were transfected with 100 nM non-targeting siRNA or Cx43 siRNA for
5 h as described in the ‘‘Materials and methods’’ section. Samples were
taken 72 h post-transfection and subjected to metabolomics analysis as
described in the ‘‘Materials and methods’’ section. Spectra of the
intracellular fraction (i.e., aqueous soluble metabolites) are shown. The
Cx43 siRNA condition, the non-targeting siRNA condition and
untreated control conditions are presented in blue, red and black,
respectively. The dotted lines show the area integrated to estimate the
levels of glycine (3.563–3.568 ppm) (colour figure online)
Fig. 6 Effect of Cx43 suppression on glycine levels in primary
hepatocyte cultures. Freshly isolated rat hepatocytes were cultivated
in a monolayer configuration. Twenty hours after plating, cell cultures
were transfected with 100 nM non-targeting siRNA or Cx43 siRNA
for 5 h as described in the ‘‘Materials and methods’’ section. Samples
were taken 72 h post-transfection and subjected to metabolomics
analysis as described in the ‘‘Materials and methods’’ section. Data
shown have been normalized using the median fold change method of
normalization and represent means per treatment group ± SD of three
independent experiments. Results were evaluated by a means of a
homoscedastic t-test
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subtle increase in glycine levels associated with Cx43
silencing (Fig. 5). Direct integration of the glycine peak
and statistical comparison of the Cx43 siRNA condition
with the non-targeting siRNA and control conditions yiel-
ded p values approaching, but not reaching significance
(i.e., 0.067 and 0.066, respectively) (Fig. 6). No significant
differences were observed in the ratio between glycine and
metabolically linked pyruvate, a strategy that does not rely
on normalization (Fig. 7).
Discussion
Connexins have emerged as multifaceted signalling entities
in the last decade, which basically relates to their assembly
status and subcellular location. Connexins indeed reside
not only at the cell plasma membrane surface, but also at
other locations, such as in the nucleus and in mitochondria
(Decrock et al. 2009; Vinken et al. 2006a, 2011a). The
latter could be supported by the results of the current
proteomics study, since a number of mitochondrial proteins
were found to be affected by Cx43 silencing in primary
hepatocyte cultures, including HSP60, GRP75, thiosul-
phate sulphurtransferase and ATP synthase. Yet, the
functional relevance of mitochondrial Cx43 is a matter of
debate. It has been postulated that Cx43 is part of a mul-
tiprotein complex that somehow controls mitochondrial
homeostasis (Goubaeva et al. 2007). In this regard, mito-
chondrial Cx43 was recently shown to be required for
respiratory complex I activity and hence for ATP
production in cardiomyocytes (Boengler et al. 2012).
Mitochondrial Cx43 could also form hemichannels and
may affect potassium ion fluxes, a scenario that equally
takes place in cardiomyocytes (Miro-Casas et al. 2009;
Rottlaender et al. 2012). This function is reminiscent of
apoptosis-regulating Bcl-2 family proteins. In fact, Cx43
was found to be an apoptosis regulator in a variety of cell
types (Decrock et al. 2009; Goubaeva et al. 2007; Klee
et al. 2011). Our group recently found that Cx43 signalling
contributes to the occurrence of spontaneous apoptosis in
freshly established cultures of primary hepatocytes, which
partially depends on connexin hemichannel functionality
(Vinken et al. 2012b). Although the results should be
considered with caution and may be speculative, the out-
come of the present global protein profiling study could
further substantiate this observation. This may equally hold
true for the metabolomic screening effort, which indicated
a tendency for increased glycine levels upon knock-down
of hepatocellular Cx43. Glycine is known to protect against
ischaemia/reperfusion injury (Luntz et al. 2005), an event
that is triggered during the isolation of primary hepatocytes
from the liver and that negatively affects cell survival
(Elaut et al. 2006). The mechanistic basis of the cytopro-
tective activity of glycine is unknown, but could involve
stabilization of the plasma membrane preventing its failure
and the onset of necrotic cell death (Kon et al. 2004) or
inhibition of calcium signalling (Menger and Vollmar
2007), a cellular process in which connexin-related com-
munication plays a prominent role (Decrock et al. 2011). In
the same context, Cx43 suppression influenced the protein
Fig. 7 Effect of Cx43 suppression on the glycine/pyruvate ratio in
primary hepatocyte cultures. Freshly isolated rat hepatocytes were
cultivated in a monolayer configuration. Twenty hours after plating,
cell cultures were transfected with 100 nM non-targeting siRNA or
Cx43 siRNA for 5 h as described in the ‘‘Materials and methods’’
section. Samples were taken 72 h post-transfection and subjected to
metabolomics analysis as described in the ‘‘Materials and methods’’
section. Data shown represent mean glycine/pyruvate ratios per
treatment group of three independent experiments. Error bars show 1
standard deviation, and results were evaluated by a means of a
homoscedastic t-test
892 Arch Toxicol (2013) 87:883–894
123
levels of two biotransformation enzymes, namely gluta-
thione S-transferase l 2 and cytochrome P450 2C70. The
former is an acknowledged detoxifier of electrophilic
compounds, including those generated during oxidative
stress (Raza 2011), which occurs in primary hepatocyte
cultures as a result of ischaemia/reperfusion insults
underwent during the two-step collagenase perfusion iso-
lation procedure (Elaut et al. 2006). The biological mean-
ing of the other protein changes induced by Cx43 silencing
in primary hepatocyte cultures is less clear. In a similar
proteomics study, using differential gel electrophoresis, it
was found that Cx43 suppression mainly affects cytoskel-
etal proteins in primary mouse astrocyte cultures (Olk et al.
2010). Our results are in line with these findings, as both
hepatocellular actin and keratin were downregulated by
Cx43 siRNA treatment.
In conclusion, the present combined proteomics/meta-
bolomics study revealed a number of cellular targets for
Cx43 knock-down in primary hepatocyte cultures. At the
same time, these data could be reconciled with the antici-
pated role of Cx43 signalling in cell death, in casu spon-
taneously occurring in primary hepatocyte cultures.
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